Elopiprazole
Elopiprazole can be used in study of neurological disease and SARS-CoV-2[1].
Product Specifications
CAS Number
115464-77-2
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/elopiprazole.html
Solubility
10 mM in DMSO
Smiles
FC1=CC=C(C2=CC=C(CN3CCN(CC3)C4=CC=CC5=C4OC=C5)N2)C=C1
Molecular Formula
C23H22FN3O
Molecular Weight
375.44
References & Citations
[1]Crespo-Facorro B, et al. Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis. Front Pharmacol. 2021;12:646701. Published 2021 Mar 2. |[2]Crespo-Facorro B, et al. Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis. Front Pharmacol. 2021;12:646701. Published 2021 Mar 2. |[3]Crespo-Facorro B, et al. Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis. Front Pharmacol. 2021;12:646701. Published 2021 Mar 2.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
